Yesterday I was reading about big pharmaceuticals eying for Indian generic players.....I know that at this time Indian generic or prescription drug market is vulnerable, there was news in march that GSK was first eying on Nicholas Piramal and then it went on closing deal with Shanta Biotech.....and later Wockhardt hospitals being acquired by Apollo group.......there are many ventures to come such as Reddy's alliance with European pharma giants, Biocon licensing with top 5 American pharma giants.....we have more to see, its just the beginning for India Inc..........I feel that Indian companies should wait for some more time and go for higher value deal than Ranbaxy labs , 10 time more than Ranbaxy-Diiachi deal.........................................What do you people say?
Sunday, June 14, 2009
Indian Pharma Inc.......................
Yesterday I was reading about big pharmaceuticals eying for Indian generic players.....I know that at this time Indian generic or prescription drug market is vulnerable, there was news in march that GSK was first eying on Nicholas Piramal and then it went on closing deal with Shanta Biotech.....and later Wockhardt hospitals being acquired by Apollo group.......there are many ventures to come such as Reddy's alliance with European pharma giants, Biocon licensing with top 5 American pharma giants.....we have more to see, its just the beginning for India Inc..........I feel that Indian companies should wait for some more time and go for higher value deal than Ranbaxy labs , 10 time more than Ranbaxy-Diiachi deal.........................................What do you people say?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment